Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Therapy in Postmenopausal Women
NCT05389943Phase 1Unknown
- Sponsor
- University of Sargodha
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of vitamin d in Vitamin D deficiency (VDD) and osteopenia (2 arms), sponsored by University of Sargodha. Primary endpoint: Bone Mineral Density at 4 months. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)osteopenia
Beyond the preview
Go deeper on NCT05389943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05389943.